ArticlebioRxiv : the preprint server for biology2023

Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation.

Shilpa S Dhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.